Trial Profile
A Randomized Controlled Trial on Integrated Management of Pronation Deformity of Children With Cerebral Palsy Treated by Botulinum Toxin-A
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Cerebral palsy; Muscle spasticity
- Focus Therapeutic Use
- 15 Apr 2020 Status changed from recruiting to completed.
- 20 Aug 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 20 Aug 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.